Page last updated: 2024-09-03

cgs 26393 and Angiospasm, Intracranial

cgs 26393 has been researched along with Angiospasm, Intracranial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CZ; Howng, SL; Jeng, AY; Kassell, NF; Kwan, AL; Lee, KS; Lin, CL; Savage, P; Winardi, D; Wu, SC; Yen, CP1

Other Studies

1 other study(ies) available for cgs 26393 and Angiospasm, Intracranial

ArticleYear
Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Administration, Oral; Animals; Aspartic Acid Endopeptidases; Basilar Artery; Dose-Response Relationship, Drug; Endothelin-Converting Enzymes; Enzyme Inhibitors; Metalloendopeptidases; Organophosphonates; Rabbits; Subarachnoid Hemorrhage; Tetrazoles; Vasospasm, Intracranial

2002